Single-Dose Neoadjuvant Pembrolizumab in Resectable Metastatic Melanoma. Shafique N, Farooq MS, Mattfeld V, Vargas GM, et al. Ann Surg Oncol 2025 Sep 12. doi: 10.1245/s10434-025-18314.

Read + Share

Amedeo Smart

Independent Medical Education

Shafique N, Farooq MS, Mattfeld V, Vargas GM, et al. Single-Dose Neoadjuvant Pembrolizumab in Resectable Metastatic Melanoma. Ann Surg Oncol 2025 Sep 12. doi: 10.1245/s10434-025-18314.
PMID: 40940600